BMO Capital Remains Bullish on Mead Johnson (MJN) Following 2Q Report
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Societe Generale Downgrades Mead Johnson Nutrition (MJN) to Hold
July 29, 2016 6:52 AM EDTSociete Generale downgraded Mead Johnson Nutrition (NYSE: MJN) from Buy to Hold with a price target of $95.00 (from $100.00).
For an analyst ratings summary and ratings history on Mead Johnson Nutrition click here. For more ratings news on Mead Johnson Nutrition click here.
Shares of Mead Johnson Nutrition closed at $89.89 yesterday.
... MoreMead Johnson (MJN) Tops Q2 EPS by 10c, Sales Miss; Reaffirms EPS Outlook
July 28, 2016 7:43 AM EDTMead Johnson (NYSE: MJN) reported Q2 EPS of $0.88, $0.10 better than the analyst estimate of $0.78. Revenue for the quarter came in at $941.5 million versus the consensus estimate of $963.66 million.
"As we move through this year, I am pleased that we continue to deliver against our... More
Trading Radar for 7/28: Alphabet (GOOG), Amazon (AMZN), Ford (F), Baidu (BIDU), MasterCard (MA) Report
July 27, 2016 2:49 PM EDTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EDT
Earnings:
ACI Worldwide, Inc. (Nasdaq: ACIW) - consensus loss $0.04
ARIAD Pharma (Nasdaq: ARIA) - consensus loss $0.11
Acorda Therapeutics (Nasdaq: ACOR) - consensus EPS $0.18
Agenus (Nasdaq: AGEN) - consensus... More
